Besides, the presence of TILs could predict a better prognosis for HCC29, indicating the enhancement of tumor T cell infiltration, particularly the CD8 T cells, may provide a potential benefit for HCC patients. This evidence concerns the gene CD8A and hepatocellular carcinoma.